Pioglin is a tablet from Renata PLC., with the generic name Pioglitazone. Pioglin 15 mg tablet is used as an add-on to diet and exercise to improve blood sugar control in type II diabetes.
There are 12 brands of Pioglitazone listed in Bangladesh. 7 of them have a lower unit price than Pioglin. The lowest listed price is Pioglinet 15 mg Tablet at ৳ 1 per unit.
What is Pioglin 15 mg Tablet?
Pioglin 15 mg is a tablet product of Renata PLC. that contains Pioglitazone. Pioglitazone works only when insulin is present in the body, so it is not used for type I diabetes or diabetic ketoacidosis. Its generic name is Pioglitazone, which belongs to the thiazolidinedione group of oral antidiabetic medicines. Whether it suits you is a decision for your doctor.
Uses of Pioglin
Pioglin 15 mg tablet is used as an add-on to diet and exercise to improve blood sugar control in type II diabetes. It is not for type I diabetes or for treating diabetic ketoacidosis. It may be prescribed on its own or in combination with a sulphonylurea, metformin or insulin when a single agent plus diet and exercise does not give adequate control. Ask your doctor whether it suits your condition.
How to use Pioglin
The tablet can generally be taken without regard to meals. Swallow the tablet with water. Pioglin is taken by mouth. Ask your doctor or pharmacist if you are unsure how to take it, and tell them about any other medicines you use. Do not change how often you take it or stop it without medical advice.
Side effects of Pioglin
Seek medical advice promptly if you develop signs of infection, unusual or persistent symptoms, or any reaction that concerns you. In clinical trials, the side effects reported with Pioglitazone included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat. Your doctor will advise on monitoring and follow-up. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
It should not be given to breastfeeding women. Pioglin should be used with caution when combined with other antidiabetic medicines and in people with liver insufficiency. There are no adequate and well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus. Ask your doctor before starting it if you are pregnant, breastfeeding, or have liver problems.
Frequently asked questions
Why is Pioglin prescribed?
Pioglin 15 mg tablet is used as an add-on to diet and exercise to improve blood sugar control in type II diabetes. It is not for type I diabetes or for treating diabetic ketoacidosis.
How is Pioglin used?
The tablet can generally be taken without regard to meals. Swallow the tablet with water.
What are the side effects of Pioglin?
Seek medical advice promptly if you develop signs of infection, unusual or persistent symptoms, or any reaction that concerns you. In clinical trials, the side effects reported with Pioglitazone included upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and sore throat.
Can I use Pioglin in pregnancy or while breastfeeding?
It should not be given to breastfeeding women. Pioglin should be used with caution when combined with other antidiabetic medicines and in people with liver insufficiency.
Pioglitazone is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Pioglitazone is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
Pharmacology
Pioglitazone is a preparation of Pioglitazone which is a member of the newest class of oral antidiabetic agent called thiazolidinediones. It depends on the presence of Insulin for its mechanism of action. Pioglitazone decreases Insulin resistance in the periphery and in the liver, resulting in increased Insulin dependent glucose disposal and decreased hepatic glucose output. It also improves abnormality in lipid metabolism by activating peroxisome proliferator activated receptor gamma (PPAR-γ).
Dosage & Administration
Pioglitazone can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Pioglitazone monotherapy may be initiated at 15 mg or 30 mg once daily dosages in patients not adequately controlled with diet and exercise alone. For patients who respond inadequately to the initial dose of Pioglitazone, the dose can be increased up to 45 mg once daily. For patients not responding adequately to monotherapy, combination therapy should be considered.
Maximum recommended daily dose of Pioglitazone should not exceed 45 mg since doses higher than 45 mg have not been studied in placebo controlled clinical studies. Besides, no placebo controlled clinical studies of more than 30 mg once daily have been conducted in combination therapy.
Interaction
Administration of thiazolidinediones with an oral contraceptive containing ethinyl oestradiol and norethindrone reduces the plasma concentration of both hormones by approximately 30% which could result in loss of contraception.
Contraindications
Pioglitazone is contraindicated in patients with known hypersensitivity to any of its components.
Side Effects
The overall incidence and types of adverse events reported in placebo controlled clinical trials of Pioglitazone monotherapy at doses of 7.5 mg, 15 mg, 30 mg or 45 mg once daily are upper respiratory tract infection (13.2%), headache (9.1%), sinusitis (6.3%), myalgia (5.4%), tooth disorder (5.3%), and pharyngitis (5.1%).
Pregnancy & Lactation
Pregnancy: There are no adequate and well controlled studies in pregnant women. Pioglitazone should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Lactation: It is not known whether Pioglitazone is secreted in human milk. As many drugs are excreted in human milk, it should not be administered to a lactating women.
Precautions & Warnings
Pioglitazone exerts its antihyperglycaemic effect only in the presence of Insulin. Therefore, it should not be used in Type 1 diabetes or for the treatment of diabetic ketoacidosis. Pioglitazone should be used with caution in case of combination antidiabetic therapy and hepatic insufficiency. Liver enzyme should be monitored regularly.
Alternative brands of Pioglitazone
Other brands with the same generic name, cheapest first.